Tag - medicine

 
 

MEDICINE

JAPAN
Jun 29, 2021
In Japan, anti-vaccine movement threatens to make widespread hesitancy worse
“Zero-risk worship” in Japan has made experts concerned about the impact that a fringe community of outspoken vaccine opponents could have on the public.
Japan Times
WORLD
Jun 28, 2021
Pfizer and Moderna vaccines likely produce long-lasting immunity
The findings add to growing evidence that most people immunized with mRNA vaccines may not need boosters, so long as the virus and its variants do not evolve much.
Japan Times
WORLD
Jun 25, 2021
WHO estimates COVID-19 boosters needed yearly for most vulnerable
A document shows that the WHO considers annual boosters for high-risk individuals as its 'indicative' baseline scenario, and boosters every two years for the general population.
Japan Times
COMMENTARY / World
Jun 22, 2021
Face masks were a booming business. Until they weren’t.
Face masks were the most ubiquitous visual symbol of the COVID-19 pandemic, but they're fading from sight as more and more people get vaccinated.
Japan Times
COMMENTARY / World
Jun 21, 2021
A scary plan to revise the definition of death in the U.S.
The current law's silence about how brain death is diagnosed means that someone could be found legally dead in Nevada even if ruled alive in Kansas.
Japan Times
WORLD
Jun 21, 2021
COVID-19 counting enters new era as threat shifts away from cases
With rich countries vaccinating growing proportions of their vulnerable populations, the link between infection numbers and deaths appears to be diminishing.
Japan Times
JAPAN / Science & Health
Jun 20, 2021
The Japanese scientist fighting prejudice, misinformation and COVID-19
Akiko Iwasaki is leading a team of immunologists hoping to beat 'long COVID-19' while also debunking myths surrounding the coronavirus.
Japan Times
WORLD / Science & Health
Jun 16, 2021
Regeneron drug reduces COVID-19 patient deaths in large study
The results suggest there would be six fewer deaths over 28 days for every 100 patients given the company's casirivimab and imdevimab combination of monoclonal antibodies.
Japan Times
COMMENTARY / World
Jun 14, 2021
Alzheimer’s drug furor highlights U.S. health system’s failures
The FDA didn't deny that the clinical-trial evidence was poor. It simply ignored that problem and used different reasoning to grant the drug 'accelerated approval.”
Japan Times
WORLD / Science & Health / ANALYSIS
Jun 11, 2021
U.S. FDA faces mounting criticism over Alzheimer's drug approval
The drug was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer's, rather than proof that it slows progression of the disease.
Japan Times
ASIA PACIFIC
Jun 11, 2021
Indians still battling impacts of COVID-19 now burdened with medical debt
Even before the pandemic struck, India's out-of-pocket expenses on health care were among the highest in the world.
Japan Times
COMMENTARY / World
Jun 10, 2021
Fixing the broken pandemic financing system
The devastation caused by COVID-19 has underscored what experts have said for years: our national, regional and global systems are grossly inadequate for detecting and containing outbreaks.
Japan Times
WORLD
Jun 9, 2021
Biggest vaccine-maker’s problems keep world short of COVID-19 shots
The Serum Institute of India's travails have become a key illustration of how the effort to inoculate against COVID-19 has failed the developing world.
Japan Times
JAPAN / Science & Health
Jun 8, 2021
Changing the game for Alzheimer's treatment, U.S. approves Eisai and Biogen's drug
The approval appears to signal a fundamental shift in the way the FDA thinks about Alzheimer's disease, which could have lasting ramifications for other drugs in the pipeline.
Japan Times
COMMENTARY / World
Jun 7, 2021
The world should learn from India’s COVID-19 cataclysm
Strategies that kept the pandemic at bay in 2020 won't necessarily work in 2021.
Japan Times
COMMENTARY / World
Jun 6, 2021
Lessons from the pandemic
Most countries are lagging far behind and new, concerted and more generous efforts by the richest nations are needed to control the pandemic at a global level.

Longform

Visitors walk past Sou Fujimoto's Grand Ring, which has been recognized as the largest wooden structure in the world.
Can a World Expo still matter? Japan is about to find out.